Bridge experience with long-term implantable left ventricular assist devices: Are they an alternative to transplantation?

Circulation

Volumn 95, Issue 7, 1997, Pages 1844-1852

  Oz, Mehmet C ^a,b   Argenziano, Michael ^a   Catanese, Katharine A ^a   Gardocki, Michael T ^a   Goldstein, Daniel J ^a   Ashton, Robert C ^a   Gelijns, Annetine C ^a   Rose, Eric A ^a   Levin, Howard R ^a  

^a New York State Psychiat Inst and New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b Milstein Hospital   (United States)

Author keywords

assist device; heart failure; transplantation

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; ASSISTED CIRCULATION; BLEEDING; COST; FEMALE; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INFECTION; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0030894978     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.7.1844     Document Type: Article

References (34)

1. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301-306.
2. Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985;55:3A. Abstract.
3. Funk D. Epidemiology of end-stage heart disease. In: Hogness JR, VanAntwerp M, eds. The Artificial Heart: Prototypes, Policies, and Patients/Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute. Washington, DC: National Academy Press; 1991:251-261.
4. Kriett JM, Kaye MP. The Registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1991;10: 491-498.
5. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
6. Franciosa JA, Ziesche WM, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary artery disease of idiopathic dilated cardiomyopathy. Am J Cardiol. 1983; 51:831-836.
7. Evans RW, Manninen DL, Garrison LP, Maier AM. Donor availability as the primary determinant of the future of heart transplantation. JAMA. 1986:255:1982-1986.
8. United Network for Organ Sharing (UNOS). UNOS Update 7. 1991;(May):2.
9. Furnary AP, Magovern JA, Chrislieb IY, Orie JE, Simpson KA, Magovern GJ. Clinical cardiomyoplasty: preoperative factors associated with outcome. Ann Thorac Surg. 1992;54:1139-1143.
10. Rose EA, Levin HR, Oz MC, Frazier H, Macmanus Q, Burton NA, Lefrak EA. Artificial circulatory support with textured interior surfaces: a counter-intuitive approach to minimize thromboembolism. Circulation. 1994;90(suppl II):II-87-II-91.
11. Medical Devices. Diagnostics and Instrumentation Reports. Chevy Chase, Md: F-D-C Reports, Inc; 1994;20:1-3.
12. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese KA, Vargo RL. McCarthy PM, Rose EA, Levin HR. Selection scale predicts patients successfully receiving long-term, implantable left ventricular assist devices. Circ. 1995;92(suppl II):II-169-II-173.
13. McCarthy PM, Wang N, Vargo R. Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device. Ann Thorac Surg. 1994;57:634-638.
14. Goldstein DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD. Smith CR, Rose EA, Levin HR, Oz MC. Use of aprotinin in LVAD recipients reduces blood loss, blood product requirement, and perioperative mortality. Ann Thorac Surg. 1995;59:1063-1068.
15. Sirchia G, Wenz B, Rebulla P, Parravicini A, Carnelli V, Bertolini F. Removal of white cells by transfusion through a new filter. Transfusion. 1990;30:30-33.
16. Cave AC, Manche A, Derias NW, Hearse DJ. Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit. J Thorac Cardiovasc Surg. 1993;106:959-967.
17. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol. 1994;10:290-297.
18. Grewal RK, Gelijns AC, Rose EA, Oz MC. Clinical costs associated with LVAD implantation. J Heart Lung Transplant. 1995;14:S89.
19. Icenogle TB, Smith RG, Cleavinger M, Vasu MA, Williams RJ, Setni GK, Copeland JG. Thromboembolic complications of the Symbion AVAD system. Artif Organs. 1989;13:532-538.
20. Levinson MM, Smith RG, Cork RC. Thromboembolic complications of the Jarvik-7 total artificial heart: case report. Artif Organs. 1989: 10:236-244.
21. Didisheim P, Olsen DB, Fara DJ, Portner PM, Griffith BP, Pennington DG. Infection and thromboembolism with implantable cardiovascular devices. Trans Am Soc Artif Intern Organs. 1987;33: 418-425.
22. Wagner WR, Johnson PC, Kormos RL, Griffith P. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients. Circulation. 1993:88(pt 1):2023-2029.
23. Aria H, Schwartz MT, Pennington DG. Importance of ventricular arrhythmias in bridge patients with ventricular assist devices. ASAIO Trans. 1991;37:M427-428.
24. Farrar DJ, Hill JD, Gray LA, Galbraith TA, Chow E, Hershon JJ. Successful biventricular circulatory support as a bridge to cardiac transplantation during prolonged ventricular fibrillation and asystole. Circulation. 1989:80(suppl III):III-147-III-141.
25. Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients chronically supported with left ventricular assist devices. J Am Coll Cardiol. 1994;24:1688-1691.
26. Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg. 1991;101:432-445.
27. Goldstein DJ, Mullis SL, Delphin ES, El-Amir N, Ashton RC, Gardocki M, Jordan DA, Catanese KA, Levin HR, Rose EA, Oz MC. Noncardiac surgery in long-term implantable left ventricular assist device recipients. Ann Surg. 1995;222:202-207.
28. Kottke FJ. The effects of limitation of activity upon the human body. JAMA. 1966;196:117-830.
29. Dean E, Ross J. Discordance between cardiopulmonary physiology and physical therapy. Chest. 1992;101:1694-1698.
30. Borg G, Linderholm H. Perceived exertion and pulse rate during graded exercise in various age groups. Acta Med Scand. 1967:472: 194-206.
31. Morrone TM, Buck LA, Catanese KA, Goldsmith RL, Cahalin LP, Oz MC, Levin HR. Early progressive mobilization of left ventricular assist device patients is safe and optimizes recovery prior to cardiac transplant. J Heart Lung Transplant. In press.
32. Pollock ML, Wilmore JH. Exercise in Health and Disease: Evaluation and Prescription for Prevention and Rehabilitation. 2nd ed. Philadelphia, Pa: WB Saunders; 1990:91-93.
33. Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin HR, Kayne HL. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327-338.
34. Levin HR, Burkoff D, Oz MC, Chen JM, Rose EA, Packer M. Reversal of ventricular remodeling in patients with end-stage heart failure by prolonged mechanical unloading. Circulation. 1995;91: 2717-2720.